Splash plans to seek U.S. regulatory approval and FDA approval for veterinary use.
3 reports, 2 independent
Updated Aug 5
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 2
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Splash plans to seek U.S. regulatory approval and FDA approval for veterinary use.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- SPLASH expanded its exclusive global license for CannEpil and is seeking a strategic joint venture for development.Sub-event
Splash is seeking FDA approval for veterinary use in the U.S.1 source